Patents Examined by Ali Soroush
  • Patent number: 11319506
    Abstract: The present invention relates to the use of a composition containing 1,8-para-menthenethiol and 3-mercaptohexyl acetate, such as a plant extract and in particular an extract of timur (Zanthoxylum armatum), as odor-masking agent. It also relates to a deodorizing product in the form of an aerosol, candle, or electrical or wick fragrance diffuser, containing this composition.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: May 3, 2022
    Assignee: JAFER ENTERPRISES R&D SL
    Inventors: Thomas Delmas, Antoine Gouteyron, Marion Perez
  • Patent number: 11318106
    Abstract: A method of treating hypoxic tissue such as wound tissue comprises contacting a composition to the hypoxic tissue in a hypoxia-treatment effective amount, the composition comprising a biodegradable polymer and an inorganic peroxide incorporated into the polymer.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: May 3, 2022
    Assignee: Wake Forest University Health Sciences
    Inventors: Benjamin S. Harrison, James J. Yoo, Anthony Atala
  • Patent number: 11304907
    Abstract: The present invention relates to a pharmaceutical composition comprising a) a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, b) one or more, e.g. 1, 2 or 3, surfactants with lubricant properties; c) one or more, e.g. 1, 2 or 3, dry binders with disintegrant properties; d) one or more, e.g. 1, 2 or 3, fillers, and e) one or more, e.g. 1, 2 or 3, disintegrants.
    Type: Grant
    Filed: March 31, 2020
    Date of Patent: April 19, 2022
    Assignee: Novartis AG
    Inventors: Hong Wen, Natrajan Kumaraperumal, Richard Nause
  • Patent number: 11291625
    Abstract: The invention relates to the fields of microbiology and health care, in particular to means and methods for minimizing the spread of hospital-acquired (HA) infections e.g. between patients and healthcare workers. Provided is an antimicrobial composition comprising an antimicrobial agent, a pharmaceutically acceptable carrier material and a polymer, the polymer being an N-vinyl lactam copolymer, and the composition being capable of forming a slow release antimicrobial film when applied to a skin surface.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: April 5, 2022
    Assignee: PolyVation B.V.
    Inventors: Joke Geesje Hagting, Theodorus Adrianus Cornelius Flipsen, Herbert Wilhelm Ulmer
  • Patent number: 11273120
    Abstract: Various compositions and methods for treating or preventing damage to hair, especially in over-processed or chemically treated hair, are described.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: March 15, 2022
    Assignee: Actera Ingredients, Inc.
    Inventors: Daniel Winn, Lorraine Lampe
  • Patent number: 11273175
    Abstract: A topical composition can be used to treat or inhibit onset of fibrillar collagenous growths, including but not limited to keloids. The composition includes elemental iodine carried in a non-migratory vehicle. Application of the composition can result in a significant reduction in the size of such a growth or, if applied to an area of skin susceptible to such a growth, inhibit the onset thereof.
    Type: Grant
    Filed: June 23, 2018
    Date of Patent: March 15, 2022
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Patent number: 11267795
    Abstract: Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate, uses of such crystalline material in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with a PPAR? agonist compound.
    Type: Grant
    Filed: July 20, 2021
    Date of Patent: March 8, 2022
    Assignee: RENEO PHARMACEUTICALS, INC.
    Inventors: Susana Del Rio Gancedo, Osama Suleiman, Emma Sharp, Cristina Balogh, Rachael Lee, Julie Macrae, Neil Feeder
  • Patent number: 11248205
    Abstract: Provided is a culture product having a mild rose aroma and suitable for imparting the rose aroma to a cosmetic product, a food or a drink, a pharmaceutical product, and the like. A culture product, which is obtained by fermenting a lactic acid bacterium culture product in a medium containing a milk component with Kluyveromyces marxianus, and comprises isoamyl alcohol in an amount of 0.3 to 5 parts by mass with respect to 1 part by mass of phenylethyl acetate.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: February 15, 2022
    Assignee: KABUSHIKI KAISHA YAKULT HONSHA
    Inventors: Naoki Izawa, Miyuki Kudo, Toshiro Sone
  • Patent number: 11246885
    Abstract: The present invention relates to a method of preventing or treating keloids using a liquid plasma. A liquid plasma according to the present invention is remarkably effective in inhibiting the generation and proliferation of keloids, thus being expected to be greatly utilized for the prevention and treatment of keloids.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: February 15, 2022
    Assignee: AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Chul Ho Kim, Sung Un Kang
  • Patent number: 11229588
    Abstract: A storage-stable solid composition comprising a tooth whitening effective amount of a particulated inorganic salt of peroxymonosulfate, and a particulated drying agent.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: January 25, 2022
    Assignee: Colgate-Palmolive Company
    Inventors: Rolando B. Plata, Devendra Chavan, Shashank Vishwanath Potnis, Manisha Jha
  • Patent number: 11219593
    Abstract: The present invention relates to a yarrow fresh plant press juice concentrate and a gentle method for its manufacture. The yarrow fresh plant press juice concentrate is used in cosmetic compositions, pharmaceutical compositions, food compositions or food supplements. This invention also relates to new aspects of the use of yarrow. The invention provides the use of yarrow to stimulate the expression of heat shock proteins and/or antimicrobial peptides in skin cells. It also describes the use of yarrow to increase the thermal tolerance of the skin.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: January 11, 2022
    Assignee: SYMRISE AG
    Inventors: Martina Herrmann, Sandra Gaebler, Manuel Pesaro, Dominik Stuhlmann, Lisa Garbe, Julia Meyer
  • Patent number: 11213564
    Abstract: A wound healing composition and method for treating acute and chronic wounds and skin conditions includes a wound healing composition or formulation including a mixture of buckwheat honey, methylglyoxal and bacitracin.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: January 4, 2022
    Assignee: SANMELIX LABORATORIES, INC.
    Inventor: Kenneth A Sabacinksi
  • Patent number: 11207276
    Abstract: A pharmaceutical dosage form includes an effective amount of L-menthol for treating a gastrointestinal disorder. The L-menthol is within a plurality of particulates having a core including crystalline L-menthol dissolved in a terpene-based essential oil. A proteinaceous coating of a continuous film of proteinaceous material is over the core.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: December 28, 2021
    Assignee: Société des Produits Nestlé S.A.
    Inventors: Syed M. Shah, Fred Hassan, Daniel Hassan, Sarah Hassan
  • Patent number: 11202447
    Abstract: The invention relates to herbicidal compositions comprising an effective amount of an active ingredient combination composed of (a) at least one substituted thien-3-ylsulfonylamino(thio)carbonyl-triazolin(thi) one of the formula (I) in which R1, R2 and R3 are as defined in the description, —or salts of the compounds of the formula (I)— and (b) one or more compounds from a second group of herbicides which comprises selected 4-HPPD inhibitors, and, if desired, additionally (c) a crop plant tolerance promoter compound. The invention further relates to the use of the compositions for controlling unwanted plant growth and to a process for producing the compositions.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: December 21, 2021
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Markus Dollinger, Hans-Joachim Santel, Ernst Rudolf Gesing, Erwin Hacker
  • Patent number: 11191717
    Abstract: Disclosed are methods useful for the topical therapeutic treatment of skin malignancies including skin cancers and cutaneous metastases using compositions containing nanoparticles of paclitaxel or other taxanes.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: December 7, 2021
    Assignee: DFB SORIA, LLC
    Inventor: Gere Dizerega
  • Patent number: 11179321
    Abstract: Compositions and methods to avoid the gag reflex to enable swallowing of pills, by applying an edible coating to the pill that generates bubbles, so that the bubbles prevent direct contact of the pill with the back of the mouth, thereby avoiding the gag reflex. Preferably the coating generates bubbles from an acid-base reaction, from compressed bubbles entrapped in hard candy, or from any other manner for creating fizzing, effervescent or popping confectionary or other food products. Optionally the coating can have a strong taste, such as by being sour, to distract away from the gag reflex. Optionally, a time release envelope is provided to delay bubbling or to block atmospheric humidity.
    Type: Grant
    Filed: November 23, 2020
    Date of Patent: November 23, 2021
    Inventor: Glen D Lindbo
  • Patent number: 11173232
    Abstract: Disclosed herein are soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and pharmaceutically acceptable salts thereof. Some of the hyaluronic acid-based compositions can include a therapeutically effective amount of at least one anesthetic agent, for example, lidocaine. Compared to conventional compositions that include lidocaine, some of the hyaluronic acid-based compositions disclosed herein can have an enhanced stability, for example, when subjected to sterilization techniques or when stored for long periods of time. Methods and processes of preparing such compositions are also provided.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: November 16, 2021
    Assignee: ALLERGAN INDUSTRIE, SAS
    Inventor: Pierre F. Lebreton
  • Patent number: 11173064
    Abstract: The present invention relates to a nanocomposite ocular device that can release drugs within a close distance to the ocular surface and provide controlled and sustained release of the drug at a constant rate. The device can achieve both optical and medical functions. The device comprises a drug, one or more reservoir domains, and a barrier layer configured to block the drug diffusion paths from the reservoir domain to the ocular surface in the eye of the subject, wherein the drug partitions between the reservoir domain and the barrier layer, and the equilibrium drug solubility in the reservoir domain is at least five folds higher than that in the barrier layer.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: November 16, 2021
    Assignee: Lynthera Corporation
    Inventors: Arthur Jing-Min Yang, Roman C. Domszy, Jeffry Chung-Hwang Yang
  • Patent number: 11166461
    Abstract: The present invention relates to methods for controlling or preventing infestation of soybean by phytopathogenic microorganisms, in particular of the Fusarium genus, Sclerotinia sclerotiorum, Microsphaera diffusa, Septoria glycines and Cercospora sojina, more particularly Fusarium virguliforme, Fusarium solani, Fusarium oxysporum, Fusarium acuminatum, Fusarium chlamydosporum, Fusarium compactum, Fusarium culmorum, Fusarium equiseti, Fusarium graminearum, Fusarium merismoides, Fusarium proliferatum, Fusarium pseudograminearum, Fusarium semitectum, Fusarium subglutinans and Fusarium verticilliodes, comprising applying to a crop of plants, the locus thereof, or propagation material thereof, a compound according to formula (I), wherein R1, R2, R3, R4, R5, Y, A, B are as defined herein.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: November 9, 2021
    Assignee: SYNGENTA PARTICIPATIONS AG
    Inventor: Matthias Gaberthueel
  • Patent number: 11166980
    Abstract: Provided herein are compositions, systems, kits, and methods for treating a viral, bacterial, protozoan, and/or fungal (e.g., onychomycosis and/or Tinea pedis) infection.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: November 9, 2021
    Assignee: Novan, Inc.
    Inventors: Ryan Doxey, Nathan Stasko, Megan Martin